Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Feb;57(2):193–197. doi: 10.1038/bjc.1988.41

Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.

K Pattanapanyasat 1, T G Hoy 1, A Jacobs 1, S Courtney 1, D J Webster 1
PMCID: PMC2246424  PMID: 2965916

Abstract

Flow cytometric studies of T-lymphocytes in breast cancer patients show that the number of cells bearing ferritin on their surface is significantly greater than normal. The number of ferritin-bearing T-cells does not appear to be related to the clinical stage of the disease nor to the serum ferritin concentration, though this is higher in cancer patients than in normal women. There is no difference in the number of T-cells positive for interleukin 2 or transferrin receptors nor in the absolute number of T-cells, T-helper cells and B-cells between normal women and those with breast cancer or benign breast disease. However, there is a significant increase in the level of HLA DR-positive T-cells and T-suppressor cells in breast cancer patients. While the significance of ferritin-bearing T-cells is not known an increase in their number appears to be associated with cancer.

Full text

PDF
193

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali F. M., May A., McLaren G. D., Jacobs A. A two-step procedure for obtaining normal peripheral blood T-lymphocytes using continuous equilibrium density gradient centrifugation on percoll. J Immunol Methods. 1982 Mar 12;49(2):185–191. doi: 10.1016/0022-1759(82)90276-9. [DOI] [PubMed] [Google Scholar]
  2. Bluestein B. I., Luderer A. A., Hess D., Smith D., Meyer K. K., Boyle G., Carter A. C. Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by radioimmunoassay. Cancer Res. 1984 Sep;44(9):4131–4136. [PubMed] [Google Scholar]
  3. Conradie J. D., Mbhele B. E. Quantitation of serum ferritin by enzyme-linked immunosorbent assay (ELISA). S Afr Med J. 1980 Feb 23;57(8):282–287. [PubMed] [Google Scholar]
  4. Cragg S. J., Hoy T. G., Jacobs A. The expression of cell surface ferritin by peripheral blood lymphocytes and monocytes. Br J Haematol. 1984 Aug;57(4):679–684. [PubMed] [Google Scholar]
  5. Dörner M. H., Silverstone A., Nishiya K., de Sostoa A., Munn G., de Sousa M. Ferritin synthesis by human T lymphocytes. Science. 1980 Aug 29;209(4460):1019–1021. doi: 10.1126/science.6967622. [DOI] [PubMed] [Google Scholar]
  6. Guesdon J. L., Ternynck T., Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem. 1979 Aug;27(8):1131–1139. doi: 10.1177/27.8.90074. [DOI] [PubMed] [Google Scholar]
  7. Hancock B. W., Bruce L., May K., Richmond J. Ferritin, a sensitizing substance in the leucocyte migration inhibition test in patients with malignant lymphoma. Br J Haematol. 1979 Oct;43(2):223–233. doi: 10.1111/j.1365-2141.1979.tb03745.x. [DOI] [PubMed] [Google Scholar]
  8. Jacobs A., Jones B., Ricketts C., Bulbrook R. D., Wang D. Y. Serum ferritin concentration in early breast cancer. Br J Cancer. 1976 Sep;34(3):286–290. doi: 10.1038/bjc.1976.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jacobs A., Miller F., Worwood M., Beamish M. R., Wardrop C. A. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J. 1972 Oct 28;4(5834):206–208. doi: 10.1136/bmj.4.5834.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jacobs A. Serum ferritin and malignant tumours. Med Oncol Tumor Pharmacother. 1984;1(3):149–156. doi: 10.1007/BF02934136. [DOI] [PubMed] [Google Scholar]
  11. Jones B. M., Worwood M. An immunoradiometric assay for the acidic ferritin of human heart: application to human tissues, cells and serum. Clin Chim Acta. 1978 Apr 3;85(1):81–88. doi: 10.1016/0009-8981(78)90104-3. [DOI] [PubMed] [Google Scholar]
  12. Ko H. S., Fu S. M., Winchester R. J., Yu D. T., Kunkel H. G. Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med. 1979 Aug 1;150(2):246–255. doi: 10.1084/jem.150.2.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Larrick J. W., Cresswell P. Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct. 1979;11(4):579–586. doi: 10.1002/jss.400110415. [DOI] [PubMed] [Google Scholar]
  14. Levy R., Kaplan H. S. Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med. 1974 Jan 24;290(4):181–186. doi: 10.1056/NEJM197401242900402. [DOI] [PubMed] [Google Scholar]
  15. Marcus D. M., Zinberg N. Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer. J Natl Cancer Inst. 1975 Oct;55(4):791–795. doi: 10.1093/jnci/55.4.791. [DOI] [PubMed] [Google Scholar]
  16. Matzner Y., Hershko C., Polliack A., Konijn A. M., Izak G. Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol. 1979 Jul;42(3):345–353. doi: 10.1111/j.1365-2141.1979.tb01142.x. [DOI] [PubMed] [Google Scholar]
  17. Moroz C., Kan M., Chaimof C., Marcus H., Kupfer B., Cuckle H. S. Ferritin-bearing lymphocytes in the diagnosis of breast cancer. Cancer. 1984 Jul 1;54(1):84–89. doi: 10.1002/1097-0142(19840701)54:1<84::aid-cncr2820540118>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  18. Moroz C., Lahat N., Biniaminov M., Ramot B. Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole. Clin Exp Immunol. 1977 Jul;29(1):30–35. [PMC free article] [PubMed] [Google Scholar]
  19. Papenhausen P. R., Emeson E. E., Croft C. B., Borowiecki B. Ferritin-bearing lymphocytes in patients with cancer. Cancer. 1984 Jan 15;53(2):267–271. doi: 10.1002/1097-0142(19840115)53:2<267::aid-cncr2820530214>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  20. Parry D. H., Worwood M., Jacobs A. Serum ferritin in acute leukaemia at presentation and during remission. Br Med J. 1975 Feb 1;1(5952):245–247. doi: 10.1136/bmj.1.5952.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pattanapanyasat K., Hoy T. G., Jacobs A. The response of intracellular and surface ferritin after T-cell stimulation in vitro. Clin Sci (Lond) 1987 Dec;73(6):605–611. doi: 10.1042/cs0730605. [DOI] [PubMed] [Google Scholar]
  22. Sarcione E. J., Smalley J. R., Lema M. J., Stutzman L. Increased ferritin synthesis and release by Hodgkin's disease peripheral blood lymphocytes. Int J Cancer. 1977 Sep 15;20(3):339–346. doi: 10.1002/ijc.2910200304. [DOI] [PubMed] [Google Scholar]
  23. Uchiyama T., Broder S., Waldmann T. A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol. 1981 Apr;126(4):1393–1397. [PubMed] [Google Scholar]
  24. Worwood M. Ferritin in human tissues and serum. Clin Haematol. 1982 Jun;11(2):275–307. [PubMed] [Google Scholar]
  25. Worwood M., Summers M., Miller F., Jacobs A., Whittaker J. A. Ferritin in blood cells from normal subjects and patients with leukaemia. Br J Haematol. 1974 Sep;28(1):27–35. [PubMed] [Google Scholar]
  26. de Sousa M., Smithyman A., Tan C. Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration. Am J Pathol. 1978 Feb;90(2):497–520. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES